IL-33 is expressed in epithelia from patients with cystic fibrosis and potentiates neutrophil recruitment

This publication has 9 references indexed in Scilit:

• Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue
  European Respiratory Journal, 2012
• IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
  Proceedings of the National Academy of Sciences, 2012
• Interleukin-33 biology with potential insights into human diseases
  Nature Reviews Rheumatology, 2011
• Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Enhances Activation of p38 and ERK MAPKs, Increasing Interleukin-6 Synthesis in Airway Epithelial Cells Exposed to Pseudomonas aeruginosa
  Journal of Biological Chemistry, 2010
• Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
  Nature Medicine, 2010
• HMGB1 and RAGE in Inflammation and Cancer
  Annual Review of Immunology, 2010
• The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
  Proceedings of the National Academy of Sciences, 2009
• Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease
  American Journal of Respiratory and Critical Care Medicine, 2008
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivo
  Proceedings of the National Academy of Sciences, 2007